Zomedica Corp (NYSE American:ZOM)
| 0.2832 Delayed Data As of Feb 03 |  -0.008 / -2.75%Today’s Change | 0.15 Today|||52-Week Range 0.50 | +73.74% Year-to-Date |
Latest ZOM News | Press Releases
No recent news for Zomedica Corp.
Today’s Trading
| Previous close | 0.29 |
| Today’s open | 0.28 |
| Day’s range | 0.28 - 0.29 |
| Volume | 6,364,648 |
| Average volume (3 months) | 9,010,075 |
| Market cap | $274.8M |
Data as of 3:49pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +58.62% |
| Earnings growth (this year) | +60.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 70.93 |
| Price/Book | 1.01 |
Competitors
| ---- | ||
| GRTSGritstone bio Inc | 0.00 | 0.00% |
| SCPHscPharmaceuticals In... | 0.00 | 0.00% |
| --China Health Group I... | 0.00 | 0.00% |
Data as of 4:00pm ET, 02/03/2023
Financials
| Next reporting date | March 1, 2023 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $4.1M |
| Annual profit (last year) | -$18.4M |
| Net profit margin | -444.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
